Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kristopher P. Heilmann
In Vitro Activity of Ceftaroline Against Clinical Isolates of Streptococcus Pneumoniae Recovered in 43 U.S. Medical Centers During 2010-2011
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Antimicrobial Resistance Among Clinical Isolates of Streptococcus Pneumoniae in the United States During 1999-2000, Including a Comparison of Resistance Rates Since 1994-1995
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
In Vitro Comparative Antimicrobial Activity of Cefpimizole Against Clinical Isolates From Five Medical Centers.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The Comparative in Vitro Activities of Three Quinolones Against Clinical Streptococcus Pneumoniae Isolates
Southern African Journal of Epidemiology and Infection
Dermatology
Epidemiology
Infectious Diseases
Activity of Ceftaroline Against Recent Emerging Serotypes of Streptococcus Pneumoniae in the United States
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative In-Vitro Activity of Ceftaroline Against Staphylococcus Aureus Isolates From India
Journal of Infection in Developing Countries
Medicine
Virology
Parasitology
Infectious Diseases
Microbiology
Ceftaroline Activity Against Bacterial Pathogens Frequently Isolated in U.S. Medical Centers: Results From Five Years of the AWARE Surveillance Program
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activities of Daptomycin Against 2,789 Clinical Isolates From 11 North American Medical Centers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Ribosomal Mutations in Streptococcus Pneumoniae Clinical Isolates
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Antibacterial Activity of Rhodanine Derivatives Against Pathogenic Clinical Isolates
PLoS ONE
Multidisciplinary
In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens From 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions
Microbial Drug Resistance
Medicine
Immunology
Microbiology
Pharmacology